Robert E. Ward
Director/Board Member presso Massachusetts High Technology Council, Inc.
Profilo
Robert E.
Ward currently works at Massachusetts High Technology Council, Inc., as Director and Antidote Therapeutics, Inc., as Director.
Mr. Ward also formerly worked at Radius Health, Inc., as President, Chief Executive Officer & Director from 2013 to 2017, Eloxx Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2017 to 2020, OncoSec Medical, Inc., as Independent Director from 2018 to 2021, Clarkson Plc, as Finance Director, Akari Therapeutics Plc, as Independent Director from 2016 to 2018, Harriman Biopartners LLC, as Managing Director from 2010 to 2011, AstraZeneca PLC, as Vice President-Strategy & External Alliances from 2011 to 2013, and NPS Pharmaceuticals, Inc., as Vice President-Corporate Development from 2006 to 2010.
Mr. Ward received his undergraduate degree from the University of California, Santa Barbara, graduate degree from New Jersey Institute of Technology, and graduate degree from The Johns Hopkins University School of Medicine.
Posizioni attive di Robert E. Ward
| Società | Posizione | Inizio |
|---|---|---|
Massachusetts High Technology Council, Inc.
 Massachusetts High Technology Council, Inc. Internet Software/ServicesTechnology Services Massachusetts High Technology Council is an organization that advocates for public policies and programs that create and maintain a competitive business climate. The non-profit company is based in Waltham, MA. The company has been nurturing tech companies for over 70 years, despite its reputation as a high-tax expensive place to do business. The Massachusetts High Technology Council provides resources and hosts events for its members, and offers membership to organizations that want to join other thought leaders in the Commonwealth. Massachusetts High Technology Council Member Testimonials are available on their website. The company was founded by Raymond S. Stata. | Director/Board Member | - |
Antidote Therapeutics, Inc.
 Antidote Therapeutics, Inc. BiotechnologyHealth Technology Antidote Therapeutics, Inc. engages in the provision of nicotine-blocking drugs to treat diseases caused or worsened by nicotine. Its product pipeline include ATI-1013, ATI 3009, and ATI-2000. The company was founded by Matthew Kalnik and is headquartered in Gaithersburg, MD. | Director/Board Member | - |
Precedenti posizioni note di Robert E. Ward
| Società | Posizione | Fine |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Director/Board Member | 23/11/2021 |
| ELOXX PHARMACEUTICALS, INC. | Chief Executive Officer | 29/02/2020 |
| AKARI THERAPEUTICS, PLC | Director/Board Member | 01/08/2018 |
| RADIUS HEALTH, INC. | Chief Executive Officer | 17/07/2017 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/12/2013 |
Formazione di Robert E. Ward
| University of California, Santa Barbara | Undergraduate Degree |
| New Jersey Institute of Technology | Graduate Degree |
| The Johns Hopkins University School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| CLARKSON PLC | Transportation |
| AKARI THERAPEUTICS, PLC | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Massachusetts High Technology Council, Inc.
Massachusetts High Technology Council, Inc. Internet Software/ServicesTechnology Services Massachusetts High Technology Council is an organization that advocates for public policies and programs that create and maintain a competitive business climate. The non-profit company is based in Waltham, MA. The company has been nurturing tech companies for over 70 years, despite its reputation as a high-tax expensive place to do business. The Massachusetts High Technology Council provides resources and hosts events for its members, and offers membership to organizations that want to join other thought leaders in the Commonwealth. Massachusetts High Technology Council Member Testimonials are available on their website. The company was founded by Raymond S. Stata. | Technology Services |
| Harriman Biopartners LLC | |
Antidote Therapeutics, Inc.
Antidote Therapeutics, Inc. BiotechnologyHealth Technology Antidote Therapeutics, Inc. engages in the provision of nicotine-blocking drugs to treat diseases caused or worsened by nicotine. Its product pipeline include ATI-1013, ATI 3009, and ATI-2000. The company was founded by Matthew Kalnik and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- Robert E. Ward
